Vaxart Inc
OTC:VXRT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vaxart Inc
OTC:VXRT
|
US |
|
G
|
Grantomato Co Ltd
TSE:7137
|
JP |
|
Ava Risk Group Ltd
ASX:AVA
|
AU |
|
One Experience SA
PAR:ALEXP
|
FR |
|
C
|
CTCI Corp
TWSE:9933
|
TW |
|
ABC Arbitrage SA
PAR:ABCA
|
FR |
|
Equita Group SpA
MIL:EQUI
|
IT |
|
Eumundi Group Ltd
ASX:EBG
|
AU |
|
S
|
Scor SE
XMUN:SDRC
|
FR |
|
SK Rosgosstrakh PAO
MOEX:RGSS
|
RU |
|
K
|
Kiattana Transport PCL
SET:KIAT
|
TH |
|
CP Axtra PCL
SET:CPAXT
|
TH |
|
Delorean Corporation Ltd
ASX:DEL
|
AU |
|
B
|
BayCom Corp
NASDAQ:BCML
|
US |
|
Toho Acetylene Co Ltd
TSE:4093
|
JP |
|
Namhae Chemical Corp
KRX:025860
|
KR |
|
F
|
Fade Gida Yatirim Sanayi Ticaret AS
IST:FADE.E
|
TR |
|
Green Plains Inc
NASDAQ:GPRE
|
US |
|
C
|
Credit Suisse Group AG
XHAM:CSX
|
CH |
|
YIT Oyj
F:YIT
|
FI |
|
F
|
Fabrinet
F:FAN
|
KY |
|
First Mining Gold Corp
TSX:FF
|
CA |
|
D
|
Deere & Co
XMUN:DCO
|
US |
|
P
|
Plus Tech Innovation PCL
SET:PTECH
|
TH |
Bankruptcy Probability
Vaxart Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vaxart Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vaxart Inc
NASDAQ:VXRT
|
121.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vaxart Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vaxart Inc has total debt of 2m USD. This includes both short-term (0 USD) and long-term (2m USD) debt.
You can find a full breakdown on its Balance Sheet.
